[pubmed] The emerging role of complement in neuromuscular disorders

[RSS-Bot]

Semin Immunopathol. 2021 Oct 27. doi: 10.1007/s00281-021-00895-4. Online ahead of print.

ABSTRACT

The complement cascade is a key arm of the immune system that protects the host from exogenous and endogenous toxic stimuli through its ability to potently regulate inflammation, phagocytosis, and cell lysis. Due to recent clinical trial successes and drug approvals for complement inhibitors, there is a resurgence in targeting complement as a therapeutic approach to prevent ongoing tissue destruction in several diseases. In particular, neuromuscular diseases are undergoing a recent focus, with demonstrated links between complement activation and disease pathology. This review aims to provide a comprehensive overview of complement activation and its role during the initiation and progression of neuromuscular disorders including myasthenia gravis, amyotrophic lateral sclerosis, and Duchenne muscular dystrophy. We will review the preclinical and clinical evidence for complement in these diseases, with an emphasis on the complement-targeting drugs in clinical trials for these indications.

PMID:34705082 | DOI:10.1007/s00281-021-00895-4


Source: https://pubmed.ncbi.nlm.nih.gov/3470508 ... 2&v=2.15.0